Assessment of bronchodilator response in preschoolers: A systematic review

Matthew D Wong1,2, Kathleena Condon2, Paul D Robinson1,2

  • 1Department of Paediatric Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Queensland, Australia.

PubMed

Insights

A universal definition for bronchodilator response (BDR) in young children is not yet possible due to varied study methods. More research is needed to establish consistent BDR thresholds for this age group.

Area of Science:

  • Pediatric Respiratory Medicine
  • Pulmonary Function Testing
  • Asthma Diagnosis

Background:

  • Assessing bronchodilator response (BDR) in preschool children (2-6 years) involves multiple techniques like spirometry and oscillometry.
  • A systematic comparison of BDR thresholds across existing studies is lacking.
  • Current literature lacks a standardized approach to defining BDR in young children.

Approach:

  • A systematic review of studies up to May 2023 was conducted to analyze BDR measurement techniques in children aged 2-6 years.
  • Searches included major databases (MEDLINE, Cochrane, EMBASE, CINAHL, Web of Science) and reference lists.
  • 43 studies were included, with a focus on methodologies for assessing BDR.

Key Points:

  • Most studies (85%) focused on European ancestry populations.
  • Only 51.2% of studies used healthy controls to establish BDR cutoffs.
  • Relative BDR was commonly reported (95%) but showed significant variability across techniques.
  • Diverse statistical methods were employed, including ROC analysis in six studies.

Conclusions:

  • A universally accepted definition for BDR in 2- to 6-year-olds is not feasible due to inconsistent methodologies and cutoff calculations.
  • Further research employing robust distribution-based or clinical anchor-based approaches is necessary.
  • Standardized methods are crucial for reliable BDR assessment in preschool-aged children.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
250
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
245
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
402